Zimmermann R, Baki S, Dengler T J, Ring G H, Remppis A, Lange R, Hagl S, Kübler W, Katus H A
Department of Cardiology, Ruprecht-Karls-University, Heidelberg, Germany.
Br Heart J. 1993 May;69(5):395-8. doi: 10.1136/hrt.69.5.395.
For the diagnosis of myocardial cell damage the measurement of the serum concentrations of myofibrillar antigens has several potential advantages over the assessment of traditional serological markers. These include the expression of myofibrillar antigens as cardiospecific isoforms and their high intracellular concentrations. Recently a sensitive and specific enzyme immunoassay for cardiac troponin T has been developed that shows little cross-reactivity with skeletal isoforms.
To characterise myocardial cell damage after orthotopic heart transplantation, concentration of circulating troponin T were measured prospectively in serial blood samples from 19 consecutive patients taken during the first three months after transplantation.
Mean (SD) serum concentrations of cardiac troponin T reached a maximum of 3.6 (1.8) micrograms/l at 7.1 (4.2) days after transplantation and remained higher than 0.5 micrograms/l (twice the detection limit of the assay) in all patients for at least 43 days (mean (SD) 59 (20) days). There was considerable variation in cumulative troponin T release (area under the concentration curve) between the patients (ranging from 27 to 150 micrograms x days/l) that was not related to the total ischaemic time before transplantation or to the patient's renal or hepatic function, preoperative cardiac diseases, major histocompatibility complex matching or the number of complications related to rejection.
Because the half life of cardiac troponin T serum is 2 h the current data show that antigen continued to be released from implanted hearts during the first postoperative months in quantities similar to minor Q wave myocardial infarction. Troponin T release after transplantation continued for much longer than after myocardial infarction or other cardiac surgery. Processes other than perioperative ischaemic damage must be responsible for the considerable individual differences in the release of cardiac troponin T.
对于心肌细胞损伤的诊断,与评估传统血清学标志物相比,测量肌原纤维抗原的血清浓度具有几个潜在优势。这些优势包括肌原纤维抗原作为心脏特异性同工型的表达及其高细胞内浓度。最近已开发出一种针对心肌肌钙蛋白T的灵敏且特异的酶免疫测定法,该方法与骨骼肌同工型几乎没有交叉反应。
为了描述原位心脏移植后心肌细胞损伤的特征,对19例连续患者移植后前三个月期间采集的系列血样中的循环肌钙蛋白T浓度进行了前瞻性测量。
心肌肌钙蛋白T的平均(标准差)血清浓度在移植后7.1(4.2)天达到最高值3.6(1.8)微克/升,并且在所有患者中至少43天(平均(标准差)59(20)天)一直高于0.5微克/升(该测定法检测限的两倍)。患者之间累积肌钙蛋白T释放量(浓度曲线下面积)存在相当大的差异(范围为27至150微克·天/升),这与移植前的总缺血时间、患者的肾功能或肝功能、术前心脏疾病、主要组织相容性复合体匹配情况或与排斥反应相关的并发症数量无关。
由于心肌肌钙蛋白T血清半衰期为2小时,目前的数据表明,在术后头几个月内,植入心脏持续释放抗原的量与小Q波心肌梗死相似。移植后肌钙蛋白T的释放持续时间比心肌梗死或其他心脏手术后长得多。围手术期缺血性损伤以外的过程必定是导致心肌肌钙蛋白T释放存在显著个体差异的原因。